Alan Wilson
Carilion Clinic(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Carcinogens and Genotoxicity Assessment, Pharmacogenetics and Drug Metabolism, Diabetes Treatment and Management, Animal testing and alternatives
Most-Cited Works
- → LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial(2012)237 cited
- → Influence of Molecular Flexibility and Polar Surface Area Metrics on Oral Bioavailability in the Rat(2004)165 cited
- → Optimization of Cryopreservation Procedures for Rat and Human Hepatocytes(1989)165 cited
- → Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract(2008)154 cited
- → Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain(2016)119 cited
- → Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)